MKGAY News and Press, Merck KGaA ADR

Palantir's stock has lost as much as 38% of its value this year and 57% from its November peak. The latest Palantir sell-off follows broader market declines that pushed the S&P 500 and tech-heavy Nasdaq 100 into correction territory last month. Markets have been extremely vola...

EMD Serono, the biopharma arm of Merck KGaA (MKGAY) and Pfizer Inc. (PFE) today announced that the European Medicines Agency has formed a positive opinion, recommending the approval of BAVENCIO® (avelumab), an antibody-based cancer therapy against urothelial carcinoma jointly d...

Merck KGaA (MKGAY) inks a three-year collaboration agreement with British biopharma outfit Artios Pharma Limited aimed at developing precision oncology drugs.The partnership will leverage the latter's proprietary nuclease-targeting discovery platform with Merck's knowhow and resources in DNA ...

Biotechvalley Insights is initiating coverage of COMPASS Pathway (CMPS) with a "Bearish" rating at a 13 PT. CMPS has filed an IPO with an initial valuation of US$544M; since then the stock has rallied 210% as of today. I think the current share price is extremely frothy. The compa...

Merck KGaA (MKGAY) wholly owned subsidiary, Ares Trading S.A. converts $25M convertible notes in Precigen (PGEN) ahead of the December 2020 maturity date, thereby raising its stake from 11,6% to 14.8%. Precigen and Merck KGaA started back in 2015, whereby both the companies ...

Novartis ([[NVS]] -1.4%) has in-licensed exclusive global rights to a Phase 2-ready program in osteoarthritis, M6495, from Merck KGaA (MKGAY).The candidate, an anti-ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5) Nanobody, was originally jointly developed by Merck K...

Biogen ([[BIIB]] +3.1%) comes up empty in its appeal of a lower court ruling invalidating a key patent covering beta-interferon, its multiple sclerosis med branded as Avonex (interferon beta-1a).It was seeking billions in royalties from Merck KGaA (MKGAY) related to its MS med Rebif (interfer...

Volatility watch: Short interest has been in an uptrend for Vale (NYSE: VALE ) and Barrick Gold (NYSE: GOLD ) , while Tootsie Roll Industries (NYSE: TR ) and Signet Jewelers (NYSE: SIG ) stand out on the list of stocks with the highest percentage of short interest as total float. M...

Pfizer (NYSE: PFE ) and Merck KGaA ( OTCPK:MKGAY ) company EMD Serono announce the publication of detailed results from the Phase III JAVELIN Bladder 100 study  at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. More news on: Pfizer Inc., Merck KGaA ADR,...

The following slide deck was published by Merck KGaA ADR in conjunction with this Read more ...